Soluble Form of Fasl (sFasL) in Adult Asthma


S Daneshmandi 1 , Ali Akbar Pourfathollah 2 , * , Z Pourpak 1 , H Heidarnazhad 1

1 Department of Immunology, Tarbiat Modares University, School of Medical Sciences, Iran

2 Department of Immunology, Tarbiat Modares University, School of Medical Sci-ences, [email protected], Iran.

How to Cite: Daneshmandi S, Pourfathollah A A, Pourpak Z, Heidarnazhad H. Soluble Form of Fasl (sFasL) in Adult Asthma, Iran Red Crescent Med J. Online ahead of Print ; 11(3):301-305.


Iranian Red Crescent Medical Journal: 11 (3); 301-305
Article Type: Research Article
Received: February 7, 2009
Accepted: May 3, 2009




Background: sFasL is the soluble form of FasL inducing apoptosis by binding to Fas. Fas/sFasL could be the most important mechanisms in inflammatory conditions such as asthma by controlling inflammatory responses. This study was undertaken to determine the level of sFasL in allergic and non- allergic asthmatic patients with different stages of asthma control.


Methods: Twenty asthmatic patients were enrolled and divided into controlled and uncontrolled patient groups. They were divided into 4 subgroups including controlled/allergic, controlled/non-allergic, uncontrolled/allergic and uncontrolled/non-allergic subgroups. Five normal subjects were selected as a control group. From all subjects, 3 ml of blood was obtained and sFasL and IgE serum levels were evaluated by a specific ELISA kit.


Results: sFasL in the controlled and uncontrolled patient groups did not have any significant difference; but in the uncontrolled/allergic subgroup, it was significantly lower than that in the control group and also higher in the uncontrolled/non-allergic subgroup insignificantly.


Conclusion: In patients with acute inflammatory conditions, sFasL had an increasing effect to control inflammation observed in uncontrolled/non-allergic subgroup, but unexpectedly not in the uncontrolled/allergic subgroup. Probably in allergic patients, there are factors or mechanisms that inhibit sFasL production or expression.


Asthma sFasL IgE Allergy

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF